These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
71 related items for PubMed ID: 11448923
21. Application of fusion protein 4D5 scFv-dibarnase:barstar-gold complex for studying P185HER2 receptor distribution in human cancer cells. Ivanova JL, Edelweiss EF, Leonova OG, Balandin TG, Popenko VI, Deyev SM. Biochimie; 2012 Aug; 94(8):1833-6. PubMed ID: 22531627 [Abstract] [Full Text] [Related]
22. Shared antigenic epitopes and pathobiological functions of anti-p185(her2/neu) monoclonal antibodies. Zhang H, Wang Q, Montone KT, Peavey JE, Drebin JA, Greene MI, Murali R. Exp Mol Pathol; 1999 Sep; 67(1):15-25. PubMed ID: 10493889 [Abstract] [Full Text] [Related]
23. Inhibition of human lung cancer cell line growth by an anti-p185HER2 antibody. Kern JA, Torney L, Weiner D, Gazdar A, Shepard HM, Fendly B. Am J Respir Cell Mol Biol; 1993 Oct; 9(4):448-54. PubMed ID: 8104437 [Abstract] [Full Text] [Related]
24. Treatment of neoplastic meningeal xenografts by intraventricular administration of an antiganglioside monoclonal antibody, 3F8. Bergman I, Barmada MA, Heller G, Griffin JA, Cheung NK. Int J Cancer; 1999 Aug 12; 82(4):538-48. PubMed ID: 10404068 [Abstract] [Full Text] [Related]
25. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic. Shepard HM, Lewis GD, Sarup JC, Fendly BM, Maneval D, Mordenti J, Figari I, Kotts CE, Palladino MA, Ullrich A. J Clin Immunol; 1991 May 12; 11(3):117-27. PubMed ID: 1679763 [Abstract] [Full Text] [Related]
26. [Leptomeningeal meningitis related to breast cancer overexpressing HER2: is there a place for a more specific treatment?]. Gutierrez M, Lyazidi S, Brasseur L, Cvitkovic F, Le Scodan R. Bull Cancer; 2011 Apr 12; 98(4):417-24. PubMed ID: 21540147 [Abstract] [Full Text] [Related]
27. Antitumor activity and toxicity of anti-HER2 immunoRNase scFv 4D5-dibarnase in mice bearing human breast cancer xenografts. Balandin TG, Edelweiss E, Andronova NV, Treshalina EM, Sapozhnikov AM, Deyev SM. Invest New Drugs; 2011 Feb 12; 29(1):22-32. PubMed ID: 19789841 [Abstract] [Full Text] [Related]
28. Construction and characterization of a recombinant human beta defensin 2 fusion protein targeting the epidermal growth factor receptor: in vitro study. Zhang M, Qiu Z, Li Y, Yang Y, Zhang Q, Xiang Q, Su Z, Huang Y. Appl Microbiol Biotechnol; 2013 May 12; 97(9):3913-23. PubMed ID: 22903275 [Abstract] [Full Text] [Related]
29. [Immunocytochemical visualization of P185(HER2) receptor by antibody fused with dibarnase and conjugate of barstar with colloidal gold]. Ivanova IuL, Edelweiss EF, Leonova OG, Balandin TG, Popenko VI, Deev SM. Mol Biol (Mosk); 2013 May 12; 47(5):806-17. PubMed ID: 25509353 [Abstract] [Full Text] [Related]
30. Differential binding patterns of monoclonal antibody 2C4 to the ErbB3-p185her2/neu and the EGFR-p185her2/neu complexes. Cai Z, Zhang G, Zhou Z, Bembas K, Drebin JA, Greene MI, Zhang H. Oncogene; 2008 Jun 19; 27(27):3870-4. PubMed ID: 18264138 [Abstract] [Full Text] [Related]
31. Enhanced endocytosis in cultured human breast carcinoma cells and in vivo biodistribution in rats of a humanized monoclonal antibody after cationization of the protein. Pardridge WM, Buciak J, Yang J, Wu D. J Pharmacol Exp Ther; 1998 Jul 19; 286(1):548-54. PubMed ID: 9655901 [Abstract] [Full Text] [Related]
32. Addition of anti-neu antibody to local irradiation can improve tumor-bearing BALB/c mouse survival through immune-mediated mechanisms. Ma SY, Song H, Park JH, Choi JH, Kim JH, Kim KH, Park S, Park DH, Kang MS, Kwak M, Fu YX, Choi I, Cho H, Park S. Radiat Res; 2015 Mar 19; 183(3):271-8. PubMed ID: 25706775 [Abstract] [Full Text] [Related]
33. Construction and characterization of novel, completely human serine protease therapeutics targeting Her2/neu. Cao Y, Mohamedali KA, Marks JW, Cheung LH, Hittelman WN, Rosenblum MG. Mol Cancer Ther; 2013 Jun 19; 12(6):979-91. PubMed ID: 23493312 [Abstract] [Full Text] [Related]
34. Differential responses of human tumor cell lines to anti-p185HER2 monoclonal antibodies. Lewis GD, Figari I, Fendly B, Wong WL, Carter P, Gorman C, Shepard HM. Cancer Immunol Immunother; 1993 Sep 19; 37(4):255-63. PubMed ID: 8102322 [Abstract] [Full Text] [Related]
35. Antibody-induced growth inhibition is mediated through immunochemically and functionally distinct epitopes on the extracellular domain of the c-erbB-2 (HER-2/neu) gene product p185. Xu F, Lupu R, Rodriguez GC, Whitaker RS, Boente MP, Berchuck A, Yu Y, DeSombre KA, Boyer CM, Bast RC. Int J Cancer; 1993 Feb 01; 53(3):401-8. PubMed ID: 7679090 [Abstract] [Full Text] [Related]
36. Prolonged survival of mice with human gastric cancer treated with an anti-c-ErbB-2 monoclonal antibody. Ohnishi Y, Nakamura H, Yoshimura M, Tokuda Y, Iwasawa M, Ueyama Y, Tamaoki N, Shimamura K. Br J Cancer; 1995 May 01; 71(5):969-73. PubMed ID: 7734322 [Abstract] [Full Text] [Related]
37. Site-specific experimental metastasis patterns of two human breast cancer cell lines in nude rats. Engebraaten O, Fodstad O. Int J Cancer; 1999 Jul 19; 82(2):219-25. PubMed ID: 10389756 [Abstract] [Full Text] [Related]
38. A rat model of leptomeningeal human neoplastic xenografts. Bergman I, Ahdab-Barmada M, Kemp SS, Griffin JA, Cheung NK. J Neurooncol; 1997 Sep 19; 34(3):221-31. PubMed ID: 9258814 [Abstract] [Full Text] [Related]
39. Evidence for intrathecal sodium butyrate as a novel option for leptomeningeal metastasis. Nakagawa H, Yui Y, Sasagawa S, Itoh K. J Neurooncol; 2018 Aug 19; 139(1):43-50. PubMed ID: 29626288 [Abstract] [Full Text] [Related]
40. Structural insights into the down-regulation of overexpressed p185(her2/neu) protein of transformed cells by the antibody chA21. Zhou H, Zha Z, Liu Y, Zhang H, Zhu J, Hu S, Shen G, Cheng L, Niu L, Greene MI, Teng M, Liu J. J Biol Chem; 2011 Sep 09; 286(36):31676-83. PubMed ID: 21680730 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]